Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 24, 2017
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 4 medicines for at least 3 months
- • at least 1 generic drug
- • at least 1 medicine of ATC code cardiovascular system (C01-10)
- Exclusion Criteria:
- • medication provided in Multicompartment Compliance Aid or similar device by specific service (pharmacy, elderly home, home care)
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, Basel Stadt, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials